Total Payments
$707.19
2024 Payments
$210.54
Companies
13
Transactions
37
Medicare Patients
5,375
Medicare Billing
$293,412
Payment Breakdown by Category
Food & Beverage$707.19 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $707.19 | 37 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $257.67 | 10 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $138.89 | 6 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $77.73 | 5 | $0 (2022) |
| PFIZER INC. | $51.31 | 3 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $34.96 | 3 | $0 (2018) |
| Melinta Therapeutics, Inc. | $25.80 | 2 | $0 (2018) |
| GlaxoSmithKline, LLC. | $25.28 | 2 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $22.16 | 1 | $0 (2024) |
| Lundbeck LLC | $18.61 | 1 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $15.77 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $210.54 | 10 | AstraZeneca Pharmaceuticals LP ($138.89) |
| 2023 | $29.76 | 2 | PFIZER INC. ($16.60) |
| 2022 | $90.53 | 6 | Kowa Pharmaceuticals America, Inc. ($77.73) |
| 2021 | $85.60 | 5 | Genentech USA, Inc. ($54.51) |
| 2020 | $50.38 | 3 | Genentech USA, Inc. ($50.38) |
| 2019 | $116.83 | 2 | Genentech USA, Inc. ($116.83) |
| 2018 | $89.58 | 6 | Genentech USA, Inc. ($35.95) |
| 2017 | $33.97 | 3 | Merck Sharp & Dohme Corporation ($22.90) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Respiratory | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Respiratory | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Respiratory | ||||||
| 05/28/2024 | AstraZeneca Pharmaceuticals LP | FLUMIST QUADRIVALENT (Biological) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Respiratory | ||||||
| 05/24/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 04/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Gastroenterology | ||||||
| 03/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Diabetes | ||||||
| 03/12/2024 | AstraZeneca Pharmaceuticals LP | FLUMIST QUADRIVALENT (Biological), AIRSUPRA | Food and Beverage | In-kind items and services | $48.56 | General |
| Category: Respiratory | ||||||
| 02/14/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/31/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 06/21/2023 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: VTE | ||||||
| 08/19/2022 | Kowa Pharmaceuticals America, Inc. | Seglentis (Drug) | Food and Beverage | Cash or cash equivalent | $13.36 | General |
| Category: Pain Management | ||||||
| 07/27/2022 | Kowa Pharmaceuticals America, Inc. | Seglentis (Drug) | Food and Beverage | Cash or cash equivalent | $17.45 | General |
| Category: Pain Management | ||||||
| 06/22/2022 | Kowa Pharmaceuticals America, Inc. | Seglentis (Drug) | Food and Beverage | Cash or cash equivalent | $15.71 | General |
| Category: Pain Management | ||||||
| 06/07/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: RESPIRATORY | ||||||
| 05/19/2022 | Kowa Pharmaceuticals America, Inc. | Seglentis (Drug) | Food and Beverage | Cash or cash equivalent | $14.02 | General |
| Category: Pain Management | ||||||
| 04/21/2022 | Kowa Pharmaceuticals America, Inc. | Seglentis (Drug) | Food and Beverage | Cash or cash equivalent | $17.19 | General |
| Category: Pain Management | ||||||
| 11/24/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Virology & Specialty Care | ||||||
| 11/04/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Virology & Specialty Care | ||||||
| 10/20/2021 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.61 | General |
| Category: NEUROLOGY | ||||||
| 01/20/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Virology & Specialty Care | ||||||
| 12/22/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Virology & Specialty Care | ||||||
| 02/10/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Virology & Specialty Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,532 | 2,193 | $213,736 | $84,465 |
| 2022 | 23 | 1,435 | 2,198 | $210,324 | $84,938 |
| 2021 | 24 | 1,252 | 1,825 | $173,846 | $70,483 |
| 2020 | 24 | 1,156 | 1,660 | $169,632 | $53,527 |
Total Patients
5,375
Total Services
7,876
Medicare Billing
$293,412
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 280 | 311 | $64,999 | $27,738 | 42.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 373 | 411 | $58,362 | $25,152 | 43.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $19,654 | $7,171 | 36.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 65 | 65 | $5,330 | $4,928 | 92.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 58 | 58 | $12,064 | $4,331 | 35.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 31 | $8,711 | $4,288 | 49.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 88 | 178 | $16,910 | $2,887 | 17.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 68 | 68 | $2,788 | $1,950 | 70.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 138 | 181 | $9,412 | $1,774 | 18.8% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 34 | 34 | $2,380 | $1,141 | 48.0% |
| 12001 | Simple repair of surface wound of scalp, neck, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 12 | 12 | $2,568 | $774.07 | 30.1% |
| 90714 | Diphtheria and tetanus vaccine (7 years or older) | Office | 2023 | 19 | 19 | $760.00 | $377.46 | 49.7% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 13 | 13 | $1,495 | $340.12 | 22.8% |
| 90471 | Administration of vaccine | Office | 2023 | 24 | 24 | $984.00 | $317.00 | 32.2% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 12 | 12 | $1,344 | $262.57 | 19.5% |
| 99421 | Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | Office | 2023 | 26 | 27 | $945.00 | $237.93 | 25.2% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 55 | 55 | $1,430 | $231.20 | 16.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 52 | 292 | $1,168 | $194.88 | 16.7% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 18 | 18 | $468.00 | $151.38 | 32.3% |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | Office | 2023 | 16 | 18 | $360.00 | $99.35 | 27.6% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 26 | 116 | $696.00 | $46.95 | 6.7% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 23 | 78 | $468.00 | $34.55 | 7.4% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2023 | 18 | 18 | $72.00 | $32.18 | 44.7% |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | Office | 2023 | 21 | 92 | $368.00 | $6.26 | 1.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 273 | 307 | $64,163 | $29,185 | 45.5% |
About Dr. Christopher Abshere, MD
Dr. Christopher Abshere, MD is a Family Medicine healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1154320901.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Abshere, MD has received a total of $707.19 in payments from pharmaceutical and medical device companies, with $210.54 received in 2024. These payments were reported across 37 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($707.19).
As a Medicare-enrolled provider, Abshere has provided services to 5,375 Medicare beneficiaries, totaling 7,876 services with total Medicare billing of $293,412. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Tulsa, OK
- Active Since 07/14/2005
- Last Updated 02/28/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1154320901
Products in Payments
- Xofluza (Drug) $257.67
- Seglentis (Drug) $77.73
- AIRSUPRA (Drug) $73.30
- FLUMIST QUADRIVALENT (Biological) $65.59
- PAXLOVID (Drug) $51.31
- SIVEXTRO (Drug) $34.96
- Baxdela (Drug) $25.80
- TRELEGY ELLIPTA (Drug) $25.28
- XIFAXAN (Drug) $22.16
- VYEPTI (Biological) $18.61
- CIPRODEX (Drug) $15.77
- JARDIANCE (Drug) $14.78
- FLOWTRIEVER CATHETER, S (Device) $13.16
- Hycofenix (Drug) $11.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Tulsa
Geoffrey Plumlee, M.d, M.D
Family Medicine — Payments: $293,576
Family Medicine $293,576
Dr. Michael Newnam, Md, MD
Family Medicine — Payments: $239,888
Family Medicine $239,888
Kimberly Hutton, Md, MD
Family Medicine — Payments: $126,859
Family Medicine $126,859
Dr. Candy Ting, D.o, D.O
Family Medicine — Payments: $43,773
Family Medicine $43,773
Dr. Sarah Hall, D.o, D.O
Family Medicine — Payments: $43,205
Family Medicine $43,205
Dr. Scott Ghere, Do, DO
Family Medicine — Payments: $30,976
Family Medicine $30,976